Provided by Tiger Fintech (Singapore) Pte. Ltd.

MAIA Biotechnology Inc.

2.10
+0.05002.44%
Post-market: 2.02-0.0800-3.81%19:56 EDT
Volume:238.48K
Turnover:477.01K
Market Cap:62.13M
PE:-2.00
High:2.10
Open:2.05
Low:1.90
Close:2.05
Loading ...

Company Profile

Company Name:
MAIA Biotechnology Inc.
Exchange:
AMEX
Establishment Date:
2018
Employees:
13
Office Location:
444 West Lake Street,Suite 1700,Chicago,Illinois,United States
Zip Code:
60606
Fax:
- -
Introduction:
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.

Directors

Name
Position
Vlad Vitoc
Co-Founder President, Chief Executive Officer, Chairman of the Board
Cristian Luput
Director
Laurentiu Vlad
Director
Louie Ngar Yee
Director
Ramiro Guerrero
Director
Stan Smith
Director
Steven Chaouki
Director

Shareholders

Name
Position
Vlad Vitoc
Co-Founder President, Chief Executive Officer, Chairman of the Board
Joseph F. McGuire
Chief Financial Officer
Mihail Obrocea
Chief Medical Officer
Sergei M. Gryaznov
Chief Scientific Officer